Latest News

Qualcomm CEO: The market is making ‘an absolute mistake’ on our stock


AbbVie’s Correction Appears to Be Over: Here’s Where the Stock Could Be Headed

AbbVie , the research-based biopharmaceutical company that was spun off from Abbott Laboratories in 2013, has made an impressive move higher the past nine years. Recently, ABBV pulled back from an April high but the correction is showing signs it is over. In the daily bar chart of ABBV, below, we can see that the shares declined below the 50-day moving average line and its slope is cresting.

Market Snapshot: Stocks close sharply higher after inflation data; Dow snaps longest weekly losing streak since 1932

Previous article

Dow Jones Rallies On Inflation Data; Tesla Jumps As Elon Musk Issues This Warning; Apple Stock Surges

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News